Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-10-16
GLYCGlycomimetics IncMagnani John L.SVP of Research, CSOS - Sale$14.01-25,00080,638-24%-$350,213
D
2018-08-13
CERCCerecor Inc.Jones Randal10%S - Sale+OE$3.98-1,2700-100%-$5,055
M
2018-10-16
ESPREsperion Therapeutics, Inc.Newton Roger SDirS - Sale$50.02-22,173576,553-4%-$1,108,997
2018-10-16
FLKSFlex Pharma, Inc.Longwood Fund Ii, L.P.10%S - Sale$0.92-3,212,8610-100%-$2,941,053
2018-10-16
CCXIChemocentryx, Inc.Glaxosmithkline PlcFormer 10% holderS - Sale$11.69-7,343,4920-100%-$85,845,421
2018-10-16
FLKSFlex Pharma, Inc.Westphal Christoph H10%S - Sale$0.92-3,212,8613,941,118-45%-$2,941,053
2018-10-18
SNGXSoligenix, Inc.Schaber Christopher JCOB, CEO, PresP - Purchase$1.17+8,70037,325+30%+$10,177
2018-10-16
MSLPMusclepharm CorpWynnefield Partners Small Cap Value LP I10%P - Purchase$1.00+15,0001,671,305+1%+$15,000
2018-10-17
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$113.25-174,696119,005,8040%-$19,783,623
D
2018-10-16
CTLTCatalent, Inc.Miyamoto LanceSVP, HRS - Sale+OE$42.50-6,52546,799-12%-$277,313
2018-10-15
IMMYImprimis Pharmaceuticals, Inc.Kammer Robert JDirS - Sale$3.00-10,000909,827-1%-$30,000
2018-10-17
SNGXSoligenix, Inc.Pearson Mark E.DirP - Purchase$1.16+170,0002,500,000+7%+$197,200
D
2018-10-15
FOLDAmicus Therapeutics IncBaird William D IIICFOS - Sale+OE$12.23-10,000117,622-8%-$122,275
A
2018-07-02
FOLDAmicus Therapeutics IncBaird William D IIICFOS - Sale$15.63-10,000117,622-8%-$156,292
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Pfizer Inc10%P - Purchase$18.00+55,55622,032,0400%+$1,000,008
2018-10-15
CALACalithera Biosciences, Inc.Orford KeithSVP, CLINICAL DEVELOPMENTS - Sale$6.05-31310,314-3%-$1,894
2018-10-15
JAZZJazz Pharmaceuticals PlcYoung Matthew P.EVP, CFOS - Sale$158.08-70032,768-2%-$110,658
2018-10-15
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasDirS - Sale$16.53-25,000361,000-6%-$413,250
DM
2018-10-15
EBSEmergent Biosolutions Inc.Havey AdamEVP, Business OperationsS - Sale+OE$61.06-22,99629,253-44%-$1,404,026
M
2018-10-15
BHCBausch Health Companies Inc.Ackermann ChristinaEVP, GCS - Sale$24.98-19,94651,456-28%-$498,302
D
2018-10-15
CTLTCatalent, Inc.Littlejohns BarryPres, Biologics, SDDS - Sale+OE$41.64-47,26537,718-56%-$1,968,115
2018-10-16
IMGNImmunogen IncBerkenblit AnnaVP, Chief Medical OfficerS - Sale$8.00-5,851132,769-4%-$46,808
2018-10-15
PRTKParatek Pharmaceuticals, Inc.Bigham MichaelCOB, CEOS - Sale$8.96-6,300264,867-2%-$56,448
2018-10-15
PRTKParatek Pharmaceuticals, Inc.Pagan Douglas W.CFOS - Sale$8.96-2,784123,220-2%-$24,945
2018-10-15
PRTKParatek Pharmaceuticals, Inc.Haskel William M.SVP, Sec., GCS - Sale$8.96-2,231102,683-2%-$19,990
2018-10-15
PRTKParatek Pharmaceuticals, Inc.Loh EvanPres, COO, CMOS - Sale$8.96-5,200289,225-2%-$46,592
2018-10-15
PRTKParatek Pharmaceuticals, Inc.Woodrow AdamVP, Chief Commercial OfficerS - Sale$8.96-2,659135,508-2%-$23,825
D
2018-10-15
ICPTIntercept Pharmaceuticals, Inc.Shapiro DavidChief Medical OfficerS - Sale+OE$102.95-3,42539,152-8%-$352,604
2018-10-12
RIGLRigel Pharmaceuticals IncCabatuan NelsonPrincipal Accounting OfficerS - Sale$3.12-10,00058-99%-$31,200
M
2018-10-09
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.05+18,00026,028,8980%+$888
2018-10-15
ACRXAcelrx Pharmaceuticals IncHamel Lawrence GChief Development OfficerS - Sale$5.00-5,21654,166-9%-$26,080
2018-10-15
ACRXAcelrx Pharmaceuticals IncDasu Badri NChief Engineering OfficerS - Sale$5.00-28,35154,061-34%-$141,755
D
2018-10-12
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale+OE$177.20-2,12539,609-5%-$376,550
2018-10-12
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$158.46-20025,172-1%-$31,692
A
2018-10-05
ECYTEndocyte IncLow Philip SChief Science OfficerS - Sale$15.56-5,928506,535-1%-$92,238
A
2018-10-05
ECYTEndocyte IncParker KatherineVP of HRS - Sale$15.55-6,77172,069-9%-$105,316
A
2018-10-05
ECYTEndocyte IncLeamon Christopher PVP of ResearchS - Sale$15.56-9,028122,219-7%-$140,437
2018-10-15
MCRBSeres Therapeutics, Inc.Aunins John G.See RemarksS - Sale$5.94-14,279103,811-12%-$84,800
2018-10-15
CBAYCymabay Therapeutics, Inc.Shah SujalCEOP - Purchase$9.90+5,000100,000+5%+$49,500
DM
2018-10-11
TXMDTherapeuticsmd, Inc.Finizio Robert GCEOS - Sale+OE$5.55-184,00020,393,559-1%-$1,020,832
D
2018-10-15
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$41.71-3,77614,700-20%-$157,497
D
2018-10-15
GTHXG1 Therapeutics, Inc.Velleca Mark A.Pres, CEOS - Sale+OE$41.53-5,00019,000-21%-$207,645
D
2018-10-15
ATNXAthenex, Inc.Wu JinnDirP - Purchase$13.47+12,500311,208+4%+$168,375
2018-10-11
CALACalithera Biosciences, Inc.Orford KeithSVP, CLINICAL DEVELOPMENTS - Sale$6.00-1,25210,627-11%-$7,512
M
2018-10-11
CORICorium International, Inc.Perceptive Advisors LLC10%S - Sale$12.52-3,632,4472,724,686-57%-$45,460,412
2018-10-11
NERVMinerva Neurosciences, Inc.Doyle William FDirP - Purchase$10.00+60012,611+5%+$6,000
M
2018-10-11
KMPHKempharm, IncSangiovanni Timothy J.VP, Corporate ControllerP - Purchase$2.52+3,0003,000New+$7,575
2018-10-12
SBOTStellar Biotechnologies, Inc.Morse Daniel E.Former DirectorS - Sale$1.31-7,04720,741-25%-$9,260
2018-10-12
SBOTStellar Biotechnologies, Inc.Oakes Frank R.Pres, CEOS - Sale$1.31-3,00051,924-5%-$3,930
M
2018-10-10
BPMXBiopharmx CorpKrammer Anja BDirS - Sale$0.19-500,0002,000,000-20%-$95,000
2018-10-12
KMPHKempharm, IncMickle Travis CPres, CEO, 10%P - Purchase$2.55+5,0002,400,1450%+$12,764
M
2018-10-10
KMPHKempharm, IncJohnson Gordon KChief Business OfficerP - Purchase$2.61+4,00010,000+67%+$10,457
2018-10-09
SPPISpectrum Pharmaceuticals IncGagnon GillesDirS - Sale$15.33-10,00072,500-12%-$153,349
DM
2018-10-09
TXMDTherapeuticsmd, Inc.Milligan John C.K. IVPres, SecretaryS - Sale+OE$5.85-250,0005,464,606-4%-$1,462,750
2018-10-10
OMEDOncomed Pharmaceuticals IncStagg RobertSVP, Clinical R, DS - Sale$2.01-92740,670-2%-$1,863
2018-10-10
OMEDOncomed Pharmaceuticals IncLi YvonneSee RemarksS - Sale$2.02-92759,734-2%-$1,873
2018-10-10
OMEDOncomed Pharmaceuticals IncGurney AustinSee RemarksS - Sale$2.01-1,15677,924-1%-$2,324
2018-10-10
OMEDOncomed Pharmaceuticals IncHager Alicia J.SVP, GCS - Sale$2.02-1,15651,754-2%-$2,335
2018-10-10
OMEDOncomed Pharmaceuticals IncLewicki John A.Pres, CEOS - Sale$2.01-1,156155,354-1%-$2,324
2018-10-11
KMPHKempharm, IncClifton R. LaduaneCFO, Secretary, TreasurerP - Purchase$2.54+6502,750+31%+$1,652
2018-10-09
ALTAltimmune, Inc.Pisano WayneDirP - Purchase$4.59+2,0002,000New+$9,180
2018-10-09
OMEDOncomed Pharmaceuticals IncLi YvonneSee RemarksS - Sale$2.13-1,22960,661-2%-$2,616
2018-10-09
OMEDOncomed Pharmaceuticals IncGurney AustinSee RemarksS - Sale$2.13-1,68679,080-2%-$3,589
2018-10-09
OMEDOncomed Pharmaceuticals IncStagg RobertSVP, Clinical R, DS - Sale$2.13-1,68641,597-4%-$3,589
2018-10-09
OMEDOncomed Pharmaceuticals IncLewicki John A.Pres, CEOS - Sale$2.13-2,296156,510-1%-$4,888
2018-10-09
OMEDOncomed Pharmaceuticals IncHager Alicia J.SVP, GCS - Sale$2.13-1,68652,910-3%-$3,589
D
2018-10-08
GTHXG1 Therapeutics, Inc.Moses Jennifer K.VP of Finance, AdminS - Sale+OE$44.52-7502,000-27%-$33,390
2018-10-09
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$115.91-10,672119,180,5000%-$1,237,013
DM
2018-10-04
TXMDTherapeuticsmd, Inc.Bernick BrianDirS - Sale+OE$5.91-182,8006,802,371-3%-$1,080,348
DM
2018-10-04
IRWDIronwood Pharmaceuticals IncCurrie Mark GChief Scientific OfficerS - Sale+OE$17.81-233,301805,124-22%-$4,155,570
D
2018-10-04
ZGNXZogenix, Inc.Farfel Gail MEVP, Chief Development OfficerS - Sale+OE$43.23-6,9617,143-49%-$300,928
M
2018-10-05
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.05+17,00026,010,8980%+$872
DM
2018-10-04
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$4.34+29,60035,060,0000%+$128,405
D
2018-10-08
CORTCorcept Therapeutics IncFishman Robert SChief Medical OfficerS - Sale+OE$13.19-8,0000-100%-$105,538
2018-10-08
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaEVP, CMOS - Sale$186.95-2,3051,909-55%-$430,920
2018-10-05
KALAKala Pharmaceuticals, Inc.Grunberg GregoryDirP - Purchase$8.25+606,0602,877,006+27%+$4,999,995
DM
2015-05-12
RAREUltragenyx Pharmaceutical Inc.Aliski WilliamDirS - Sale+OE$72.49-19,550283,310-6%-$1,417,098
AD
2018-08-21
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP, GCS - Sale+OE$78.53-5,00014,181-26%-$392,650
2018-10-08
LGNDLigand Pharmaceuticals IncDavis Todd CDirS - Sale$253.99-2,50042,556-6%-$634,978
D
2018-10-05
AGIOAgios Pharmaceuticals IncBiller ScottChief Scientific OfficerS - Sale+OE$69.79-3,00057,196-5%-$209,377
2018-10-05
KMPHKempharm, IncDelaware Street Capital Master Fund, L.P.10%P - Purchase$3.00+2,000,0004,095,914+95%+$6,000,000
2018-10-05
ECYTEndocyte IncArmour Alison A.Chief Medical OfficerS - Sale$15.56-9,111101,040-8%-$141,748
2018-10-05
ECYTEndocyte IncLeamon Christopher PVP of ResearchS - Sale$15.56-9,028121,353-7%-$140,437
2018-10-05
ECYTEndocyte IncTaylor BethVP Finance, Chief Acctg OffcrS - Sale$15.56-7,02256,341-11%-$109,287
2018-10-05
ECYTEndocyte IncSherman Michael A.Pres, CEOS - Sale$15.55-28,146367,837-7%-$437,752
M
2018-10-05
ECYTEndocyte IncAndriole Michael T.CFOS - Sale$15.56-17,918132,082-12%-$278,848
2018-10-05
ECYTEndocyte IncChelius Erik C.VP CMCS - Sale$15.56-4,51449,895-8%-$70,243
2018-10-05
ECYTEndocyte IncParker KatherineVP of HRS - Sale$15.55-6,77171,549-9%-$105,316
2018-10-05
ECYTEndocyte IncLow Philip SChief Science OfficerS - Sale$15.56-5,928504,802-1%-$92,238
2018-10-08
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$115.91-14,632119,191,1720%-$1,696,039
D
2018-10-08
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$15.75-12,5001,320,271-1%-$196,832
D
2018-10-08
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$15.75-12,5001,320,271-1%-$196,832
D
2018-10-04
MYOKMyokardia IncGianakakos AnastasiosPres, CEOS - Sale+OE$58.19-3,000697,5220%-$174,578
2018-10-05
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale$8.79-4,000164,188-2%-$35,178
2018-10-05
ICPTIntercept Pharmaceuticals, Inc.Shapiro DavidChief Medical OfficerS - Sale$110.65-75939,152-2%-$83,983
2018-10-05
EPZMEpizyme, Inc.Mott David MDirP - Purchase$9.00+416,6676,890,257+6%+$3,750,003
D
2018-10-04
GTHXG1 Therapeutics, Inc.Rudnick SethDirS - Sale+OE$49.72-10,00058,282-15%-$497,210
D
2018-10-03
GTHXG1 Therapeutics, Inc.Murdock Terry LSVP of Development OperationsS - Sale+OE$49.18-3,5190-100%-$173,064
2018-10-03
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$98.98-1,00049,135-2%-$98,985
2018-10-03
PTIEPain Therapeutics IncArmistice Capital, LLC10%S - Sale$1.31-512,6601,651,340-24%-$671,738
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top